Trial intelligence / Profile preview

7% hypertonic saline nebulization in chemical warfare veterans with sulfur mustard-related lung disease

IRCT20250524065876N1Phase 3Completed

Sponsor
Baqiyatallah University of Medical Sciences
Start
Sep 2025
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of sodium chloride in chemical pneumonitis (2 arms), sponsored by Baqiyatallah University of Medical Sciences. Primary endpoints: Forced expiratory volume in 1 second, Forced vital capacity and 6 more. Started Sep 2025; status: completed.

02

Drugs

sodium chloride
03

Conditions

chemical pneumonitis

Beyond the preview

Go deeper on IRCT20250524065876N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250524065876N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call